Angiogenesis inhibitors for lung cancer: Clinical developments and future directions

被引：3
|
作者：
Blumenschein, George
Heymach, John V.
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2006年 / 1卷 / 07期
关键词：
D O I：
10.1016/S1556-0864(15)30398-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：744 / 748
页数：5
相关论文
共 50 条
  • [1] Sorafenib in lung cancer: Clinical developments and future directions
    Blumenschein, George, Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S124 - S127
  • [2] Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions
    Lin, Zhexuan
    Zhang, Quanwei
    Luo, Wenhong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 793 : 76 - 81
  • [3] Angiogenesis inhibitors: Current & future directions
    Mousa, SA
    Mousa, AS
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (01) : 1 - 9
  • [4] Angiogenesis inhibitors in clinical development for lung cancer
    Herbst, RS
    Hidalgo, M
    Pierson, AS
    Holden, SN
    Bergen, M
    Eckhardt, SG
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 66 - 77
  • [5] First-line immune checkpoint inhibitors for extensive stage small-cell lung cancer: clinical developments and future directions
    Ortega-Franco, A.
    Ackermann, C.
    Paz-Ares, L.
    Califano, R.
    ESMO OPEN, 2021, 6 (01)
  • [6] Src Inhibitors in Lung Cancer: Current Status and Future Directions
    Rothschild, Sacha I.
    Gautschi, Oliver
    Haura, Eric B.
    Johnson, Faye M.
    CLINICAL LUNG CANCER, 2010, 11 (04) : 238 - 242
  • [7] Angiogenesis inhibitors in lung cancer
    Giaccone, G.
    ANNALS OF ONCOLOGY, 2007, 18 : 20 - 20
  • [8] Angiogenesis inhibitors in lung cancer
    Gauler, T
    Hepp, R
    Korfee, S
    Eberhardt, W
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 283 - 290
  • [9] Lung cancer: Future directions
    Lam, Wah K.
    Watkins, D. Neil
    RESPIROLOGY, 2007, 12 (04) : 471 - 477
  • [10] Checkpoint inhibitors in lung cancer: latest developments and clinical potential
    Schvartsman, Gustavo
    Ferrarotto, Renata
    Massarelli, Erminia
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (06) : 460 - 473
12345